Stock listing

Boule Diagnostics Ab

Selected listing: A2JMYV · LS · EUR · DE

Boule Diagnostics Ab (Lang & Schwarz: A2JMYV), Health Technology. Latest release Jul 17, 2026: Boule Diagnostics Interim Report Q2 2026.

A2JMYV:LSEURDEUpdated September 26, 2026

Ticker: Lang & Schwarz: A2JMYV
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: Lang & Schwarz
Currency: EUR

About Boule Diagnostics Ab

The company specializes in diagnostic solutions, focusing on hematology and blood analysis. Boule Diagnostics is committed to providing high-quality products and services to enhance laboratory efficiency and patient care.

Latest news from Boule Diagnostics Ab

Boule Diagnostics Interim Report Q2 2026

July 17, 2026

Boule Diagnostics Appoints Johan Folkunger As New CEO

June 18, 2026

Boule Diagnostics Appoints Simonetta Tumbiolo As Interim CEO

May 29, 2026

Bulletin from the Annual General Meeting May 13, 2026 in Boule Diagnostics

May 13, 2026

BOUL: Organic growth and positive cash flow achieved despite currency headwinds and lower sales

April 28, 2026

All Boule Diagnostics Ab news →

Events

Replays

Boule Diagnostics AB (BOUL) Q2 2026 Earnings Call
Fri, Jul 17, 2026 · 04:00 AM ET
Watch
Boule Diagnostics AB (BOUL) Q1 2026 Earnings Call
Tue, Apr 28, 2026 · 04:00 AM ET
Watch
Boule Diagnostics AB (BOUL) Q4 2025 Earnings Call
Wed, Feb 11, 2026 · 02:00 AM ET
Watch

Research Boule Diagnostics Ab

Boule Diagnostics Ab company profile

View the public company page for Boule Diagnostics Ab on 6ix.

Boule Diagnostics Ab news

Read company news and market updates connected to Boule Diagnostics Ab.

Boule Diagnostics Ab investor events

Find investor webinars, events, and replay context for Boule Diagnostics Ab.